Comparisons of Percutaneous Ablation, Open or Laparoscopic Liver Resection for Barcelona Clinic Liver Cancer Stage 0-A Hepatocellular Carcinoma: A Concurrent Generalized Propensity Score Analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Singal AG, Zhang E, Narasimman M, et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;77(1):128–139. doi:10.1016/j.jhep.2022.01.023
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl. 2014;20(5):528–535. doi:10.1002/lt.23820
   PubMed Web of Science ®Google Scholar
• Schmelzle M, Krenzien F, Schöning W, Pratschke J. Laparoscopic liver resection: indications, limitations, and economic aspects. Langenbecks Arch Surg. 2020;405(6):725–735. doi:10.1007/s00423-020-01918-8
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–328. doi:10.1097/01.sla.0000201480.65519.b8
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57(4):794–802. doi:10.1016/j.jhep.2012.05.007
   PubMed Web of Science ®Google Scholar
• Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29(1):193–200. doi:10.1111/jgh.12441
   PubMed Web of Science ®Google Scholar
• Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF Trial). Liver Cancer. 2021;11(3):209–218. doi:10.1159/000521665
   PubMed Web of Science ®Google Scholar
• Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903–912. doi:10.1097/SLA.0b013e3181efc656
   PubMed Web of Science ®Google Scholar
• El-Gendi A, El-Shafei M, El-Gendi S, Shawky A. Laparoscopic versus open hepatic resection for solitary hepatocellular carcinoma less than 5 cm in cirrhotic patients: a randomized controlled study. J Laparoendosc Adv Surg Tech A. 2018;28(3):302–310. doi:10.1089/lap.2017.0518
   PubMed Web of Science ®Google Scholar
• Wang JH, Wang CC, Hung CH, Chen CL, Lu SN. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol. 2012;56(2):412–418. doi:10.1016/j.jhep.2011.05.020
   PubMed Web of Science ®Google Scholar
• Hung HH, Chiou YY, Hsia CY, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol. 2011;9(1):79–86. doi:10.1016/j.cgh.2010.08.018
   PubMed Web of Science ®Google Scholar
• Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology. 2012;262(3):1022–1033. doi:10.1148/radiol.11110817
   PubMed Web of Science ®Google Scholar
• Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47(1):82–89. doi:10.1002/hep.21933
   PubMed Web of Science ®Google Scholar
• Chu HH, Kim JH, Kim PN, et al. Surgical resection versus radiofrequency ablation very early-stage HCC (</=2 cm Single HCC): a propensity score analysis. Liver Int. 2019;39(12):2397–2407. doi:10.1111/liv.14258
   PubMed Web of Science ®Google Scholar
• Liu PH, Hsu CY, Hsia CY, et al. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma </= 2 cm in a Propensity Score Model. Ann Surg. 2016;263(3):538–545. doi:10.1097/SLA.0000000000001178
   PubMed Web of Science ®Google Scholar
• Zhu P, Liao W, Zhang WG, et al. A prospective study using propensity score matching to compare long-term survival outcomes after robotic-assisted, laparoscopic or open liver resection for patients with BCLC stage 0-A hepatocellular carcinoma. Ann Surg. 2023;277(1):e103–e111. doi:10.1097/SLA.0000000000005380
   PubMed Web of Science ®Google Scholar
• Takahara T, Wakabayashi G, Beppu T, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22(10):721–727. doi:10.1002/jhbp.276
   PubMed Web of Science ®Google Scholar
• Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol. 2015;63(3):643–650. doi:10.1016/j.jhep.2015.04.005
   PubMed Web of Science ®Google Scholar
• Troisi RI, Berardi G, Morise Z, et al. Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study. Br J Surg. 2021;108(2):196–204. doi:10.1093/bjs/znaa041
   PubMed Web of Science ®Google Scholar
• Ogiso S, Seo S, Eso Y, et al. Laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma. HPB. 2021;23(4):533–537. doi:10.1016/j.hpb.2020.08.009
   PubMed Web of Science ®Google Scholar
• Song J, Wang Y, Ma K, et al. Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas. Surg Endosc. 2016;30(10):4249–4257. doi:10.1007/s00464-015-4737-1
   PubMed Web of Science ®Google Scholar
• Lee DH, Kim JW, Lee JM, et al. Laparoscopic liver resection versus percutaneous radiofrequency ablation for small single nodular hepatocellular carcinoma: comparison of treatment outcomes. Liver Cancer. 2021;10(1):25–37. doi:10.1159/000510909
   PubMed Web of Science ®Google Scholar
• Piantadosi S. Clinical Trials: A Methodologic Perspective. 2nd ed. Wiley; 2006.
   Google Scholar
• Juszczak E, Altman DG, Hopewell S, Schulz K. Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement. JAMA. 2019;321(16):1610–1620. doi:10.1001/jama.2019.3087
   PubMed Web of Science ®Google Scholar
• von EE, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Xie W, Tan J, Li B, et al. Comparison of hepatic resection with percutaneous ablation for hepatocellular carcinoma in the caudate lobe within Milan criteria. J Gastrointest Surg. 2022;26(2):323–332. doi:10.1007/s11605-021-05111-0
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae
   PubMed Web of Science ®Google Scholar
• Feng P, Zhou XH, Zou QM, Fan MY, Li XS. Generalized propensity score for estimating the average treatment effect of multiple treatments. Stat Med. 2012;31(7):681–697. doi:10.1002/sim.4168
   PubMed Web of Science ®Google Scholar
• McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32(19):3388–3414. doi:10.1002/sim.5753
   PubMed Web of Science ®Google Scholar
• Rassen JA, Shelat AA, Franklin JM, Glynn RJ, Solomon DH, Schneeweiss S. Matching by propensity score in cohort studies with three treatment groups. Epidemiology. 2013;24(3):401–409. doi:10.1097/EDE.0b013e318289dedf
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhang M, Shi X, Caram MEV, Little RJA, Mukherjee B. A comparison of parametric propensity score-based methods for causal inference with multiple treatments and a binary outcome. Stat Med. 2021;40(7):1653–1677. doi:10.1002/sim.8862
   PubMed Web of Science ®Google Scholar
• Yoshida K, Hernandez-Diaz S, Solomon DH, et al. Matching weights to simultaneously compare three treatment groups: comparison to three-way matching. Epidemiology. 2017;28(3):387–395. doi:10.1097/EDE.0000000000000627
   PubMed Web of Science ®Google Scholar
• Thomas L, Li F, Pencina M. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323(23):2417–2418. doi:10.1001/jama.2020.7819
   PubMed Web of Science ®Google Scholar
• Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107. doi:10.1002/sim.3697
   PubMed Web of Science ®Google Scholar
• Syriopoulou E, Wästerlid T, Lambert PC, Andersson TM. Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data. Br J Cancer. 2022;127(10):1808–1815. doi:10.1038/s41416-022-01949-6
   PubMed Web of Science ®Google Scholar
• Liu XR, Pawitan Y, Clements M. Parametric and penalized generalized survival models. Stat Methods Med Res. 2018;27(5):1531–1546. doi:10.1177/0962280216664760
   PubMed Web of Science ®Google Scholar
• Hirst A, Philippou Y, Blazeby J, et al. No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations. Ann Surg. 2019;269(2):211–220. doi:10.1097/SLA.0000000000002794
   PubMed Web of Science ®Google Scholar
• Xu XL, Liu XD, Liang M, Luo BM. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. 2018;287(2):461–472. doi:10.1148/radiol.2017162756
   PubMed Web of Science ®Google Scholar
• Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ. Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: a Systematic Review and Meta-analysis. Ann Surg. 2021;273(4):656–666. doi:10.1097/SLA.0000000000004350
   PubMed Web of Science ®Google Scholar
• Yang J, Guo W, Lu M. Recent Perspectives on the mechanism of recurrence after ablation of hepatocellular carcinoma: a mini-review. Front Oncol. 2022;12:895678. doi:10.3389/fonc.2022.895678
   PubMed Web of Science ®Google Scholar
• Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma </=3 cm. Results of a multicenter Italian survey. J Hepatol. 2013;59(1):89–97. doi:10.1016/j.jhep.2013.03.009
   PubMed Web of Science ®Google Scholar
• Kuhry E, Jeekel J, Bonjer HJ. Effect of laparoscopy on the immune system. Semin Laparosc Surg. 2004;11(1):37–44. doi:10.1177/107155170401100107
   PubMedGoogle Scholar
• Tang F, Tie Y, Tu C, Wei X. Surgical trauma-induced immunosuppression in cancer: recent advances and the potential therapies. Clin Transl Med. 2020;10(1):199–223. doi:10.1002/ctm2.24
   PubMed Web of Science ®Google Scholar
• Abu Hilal M, Aldrighetti L, Dagher I, et al. The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg. 2018;268(1):11–18. doi:10.1097/SLA.0000000000002524
   PubMed Web of Science ®Google Scholar
• Ibuki S, Hibi T, Tanabe M, et al. Short-term outcomes of “Difficult” laparoscopic liver resection at specialized centers: report from INSTALL (International Survey on Technical Aspects of Laparoscopic Liver Resection)-2 on 4478 patients. Ann Surg. 2022;275(5):940–946. doi:10.1097/SLA.0000000000004434
   PubMed Web of Science ®Google Scholar
• Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43(5):1101–1108. doi:10.1002/hep.21164
   PubMed Web of Science ®Google Scholar
• Kwak MH, Lee MW, Ko SE, et al. Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma. Ultrasonography. 2022;41(3):543–552. doi:10.14366/usg.21241
   PubMed Web of Science ®Google Scholar
• Eun HS, Lee BS, Kwon IS, et al. Advantages of laparoscopic radiofrequency ablation over percutaneous radiofrequency ablation in hepatocellular carcinoma. Dig Dis Sci. 2017;62(9):2586–2600. doi:10.1007/s10620-017-4688-6
   PubMed Web of Science ®Google Scholar